Cryocon, Inc. Appoints Dr. Richard Lindstrom to Board of Directors; Acclaimed Eye Surgeon to Head New Company Medical Division

Apr 25, 2001, 01:00 ET from Cryocon, Inc.

    OGDEN, Utah, April 25 /PRNewswire/ -- Cryocon, Inc.
 (OTC Bulletin Board:   CRYQ), an Ogden, Utah based public company that provides
 a material treatment process called Deep Cryogenic Tempering (DCT), today
 announced that it has appointed Richard L. Lindstrom, M.D. to the company's
 board of directors.  Dr. Lindstrom, who previously was involved with Cryocon
 in testing cryogenically treated surgical cutting instruments, was also
 appointed as medical director of a new company division.  The division will be
 based in Minneapolis, Minnesota and will focus on developing DCT applications
 for medical and surgical instruments and devices.
     "We're thrilled to have Dr. Lindstrom join our organization," Cryocon
 Chairman/CEO J. Brian Morrison said.  "He brings an unmatched level of
 credibility and industry presence.  We feel that there is a huge opportunity
 for this technology in enhancing the performance and wear characteristics of
 materials used in the medical industry."
     "I'm very excited about the potential of Deep Cryogenic Tempering's
 ability to enhance the performance of surgical instruments," Dr. Lindstrom
 said.  "This technology can potentially improve patient outcomes through
 enhanced instrument performance in nearly all fields of medical care and
 surgery."
     Dr. Lindstrom has previously been awarded 29 patents and 15 research
 grants.  He is currently the attending surgeon and managing partner of
 Minnesota Eye Consultants in Minneapolis.  Dr. Lindstrom also serves as an
 attending surgeon and medical director for the Center for Teaching and
 Research at the Phillips Eye Institute.  He is the medical director for Laser
 Vision Centers, Inc. and Midwest Surgical Services, and is the chief medical
 editor for Ocular Surgery News.  Dr. Lindstrom frequently consults with
 industry leaders and serves as president of Ophthalmology Consultants.  He is
 the associate director for the Minnesota Lions' Eye Bank and a clinical
 professor of Ophthalmology at the University of Minnesota.
     DCT is a computer-controlled tempering process that significantly improves
 the wear and performance characteristics of many types of metals, alloys, and
 synthetic materials.  DCT utilizes liquid nitrogen that is flashed to a gas to
 achieve temperatures of minus 300 degrees Fahrenheit.  Treated items show
 dramatic increases in wear resistance, toughness, machinability, thermal and
 dimensional stability.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X13300266
 
 

SOURCE Cryocon, Inc.
    OGDEN, Utah, April 25 /PRNewswire/ -- Cryocon, Inc.
 (OTC Bulletin Board:   CRYQ), an Ogden, Utah based public company that provides
 a material treatment process called Deep Cryogenic Tempering (DCT), today
 announced that it has appointed Richard L. Lindstrom, M.D. to the company's
 board of directors.  Dr. Lindstrom, who previously was involved with Cryocon
 in testing cryogenically treated surgical cutting instruments, was also
 appointed as medical director of a new company division.  The division will be
 based in Minneapolis, Minnesota and will focus on developing DCT applications
 for medical and surgical instruments and devices.
     "We're thrilled to have Dr. Lindstrom join our organization," Cryocon
 Chairman/CEO J. Brian Morrison said.  "He brings an unmatched level of
 credibility and industry presence.  We feel that there is a huge opportunity
 for this technology in enhancing the performance and wear characteristics of
 materials used in the medical industry."
     "I'm very excited about the potential of Deep Cryogenic Tempering's
 ability to enhance the performance of surgical instruments," Dr. Lindstrom
 said.  "This technology can potentially improve patient outcomes through
 enhanced instrument performance in nearly all fields of medical care and
 surgery."
     Dr. Lindstrom has previously been awarded 29 patents and 15 research
 grants.  He is currently the attending surgeon and managing partner of
 Minnesota Eye Consultants in Minneapolis.  Dr. Lindstrom also serves as an
 attending surgeon and medical director for the Center for Teaching and
 Research at the Phillips Eye Institute.  He is the medical director for Laser
 Vision Centers, Inc. and Midwest Surgical Services, and is the chief medical
 editor for Ocular Surgery News.  Dr. Lindstrom frequently consults with
 industry leaders and serves as president of Ophthalmology Consultants.  He is
 the associate director for the Minnesota Lions' Eye Bank and a clinical
 professor of Ophthalmology at the University of Minnesota.
     DCT is a computer-controlled tempering process that significantly improves
 the wear and performance characteristics of many types of metals, alloys, and
 synthetic materials.  DCT utilizes liquid nitrogen that is flashed to a gas to
 achieve temperatures of minus 300 degrees Fahrenheit.  Treated items show
 dramatic increases in wear resistance, toughness, machinability, thermal and
 dimensional stability.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X13300266
 
 SOURCE  Cryocon, Inc.